Is Lipella Pharmaceuticals Inc. (LIPO) a Buy, Sell, or Hold?
OTC : LIPO
Lipella Pharmaceuticals Inc.
$0.065 USD
$0.0 (-5.91%)
- Volume
- 10.3K
- Average Volume
- 43.43K
- Market Capitalization
- $300.35K
- P/E Ratio
- -0.05
- Dividend Yield
- 0.00%
- Price Target
- $2.00
- Year High
- $0.80
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.24
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Jonathan Kaufman |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | LIPO |
| CUSIP | 53630L209 |
| CIK | 0001347242 |
| Web | https://www.lipella.com |
| Phone | 412-894-1853 |
| Currency | USD |
| Employees | 7 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.18 |
| Payout Ratio | 0.00 |
| Current Ratio | 3.24 |
| Quick Ratio | 3.24 |
| Cash Ratio | 2.89 |
Sales & Book Value
| Annual Sales | $536.36K |
| Price / Sales | 0.00 |
| Cash Flow | -518.92 |
| Price / Cash Flow | 0.00 |
| Price / Book | 0.20 |
Price Target and Rating
| Average Stock Price Forecast | $2.00 |
| High Stock Price Forecast | $2.00 |
| Low Stock Price Forecast | $2.00 |
| Forecast Upside/Downside | -96.75% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$4.79 |
| Trailing P/E Ratio | -0.05 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | -$5.02M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | -140.39% |
| Return on Assets | -165.46% |
Financials Score
| AltmanZ Score | -17.92 |
| Piotroski Score | 1.00 |
| Working Capital | 1.44M |
| Total Assets | 2.35M |
| Ebit | -5.33M |
| Market Cap | 300.35K |
| Total Liabilities | 862.22K |
Poll Results
About Lipella Pharmaceuticals Inc. (OTC:LIPO) Stock
Lipella Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the creation of novel therapies. The company achieves this by repurposing and optimizing the active ingredients found in established generic drugs, tailoring these reformulations for diverse medical applications. Its lead candidate, LP-10, a tacrolimus formulation, is presently in Phase IIa clinical studies, targeting radiation-induced hemorrhagic cystitis. Additionally, LP-310, another tacrolimus-derived compound, is under development for the management of oral lichen planus. Founded in 2005, the company maintains its headquarters in Pittsburgh, Pennsylvania. ...
Frequently Asked Questions
-
What is the current Lipella Pharmaceuticals Inc. (LIPO) stock price?
-
Lipella Pharmaceuticals Inc.(OTC:LIPO) stock price is $0.065 in the last trading session. During the trading session, LIPO stock reached the peak price of $0.8 while $0.02 was the lowest point it dropped to. The percentage change in LIPO stock occurred in the recent session was --5.91% while the dollar amount for the price change in LIPO stock was -$0.0.
-
LIPO's industry and sector of operation?
-
The OTC listed LIPO is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of LIPO?
-
Jonathan Kaufman | Co-Founder, Chairman, Chief Executive Officer, President, Secretary & Treasurer
Douglas Johnston | Chief Financial Officer
Katie Johnston | Controller
Janet Okonski | Director of Clinical Operations
Michele Gruber | Director of Operations -
How many employees does LIPO have?
-
Number of LIPO employees currently stands at 7. LIPO operates from 7800 Susquehanna St., Pittsburgh, PA 15208, US.
-
Link for LIPO official website?
-
Official Website of LIPO is: https://www.lipella.com
-
How do I contact LIPO?
-
LIPO could be contacted at phone #412-894-1853 and can also be accessed through its website. LIPO operates from 7800 Susquehanna St., Pittsburgh, PA 15208, US.
-
How many shares of LIPO are traded daily?
-
The average number of LIPO shares traded daily for last 3 months was 43.43K.
-
What is the market cap of LIPO currently?
-
The market value of LIPO currently stands at $300.35K with its latest stock price at $0.065